Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Alibaba Health Information Technology Unsponsored ADR Representing 20 Ord Shs ALBBY

Alternate Symbol(s):  ALBHF

Alibaba Health Information Technology Ltd is an investment holding company mainly engaged in the provision of Internet solutions for the medical and pharmaceutical industry, and is Alibaba Group’s healthcare flagship platform. The Company is mainly involved in the development of pharmaceutical and healthcare product and service sales business, the operation of pharmaceutical e-commerce platform... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (PINL:ALBBY)

No current news is available.

Opinion & Analysis (PINL:ALBBY)

No current opinion is available.

Bullboard Posts (PINL:ALBBY)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
ScarletteBourne - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
ScarletteBourne - July 13, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
ScarletteBourne - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
ScarletteBourne - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
ScarletteBourne - May 10, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
ScarletteBourne - May 1, 2022